SE9803517D0 - Pharmaceutical preparation - Google Patents

Pharmaceutical preparation

Info

Publication number
SE9803517D0
SE9803517D0 SE9803517A SE9803517A SE9803517D0 SE 9803517 D0 SE9803517 D0 SE 9803517D0 SE 9803517 A SE9803517 A SE 9803517A SE 9803517 A SE9803517 A SE 9803517A SE 9803517 D0 SE9803517 D0 SE 9803517D0
Authority
SE
Sweden
Prior art keywords
compound
preparations
present
salt
counterion
Prior art date
Application number
SE9803517A
Other languages
English (en)
Inventor
Annika Bjoere
Anna-Karin Granath
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9803517A priority Critical patent/SE9803517D0/sv
Publication of SE9803517D0 publication Critical patent/SE9803517D0/sv
Priority to BR9906869-9A priority patent/BR9906869A/pt
Priority to TR2000/01760T priority patent/TR200001760T1/xx
Priority to IL13642899A priority patent/IL136428A0/xx
Priority to KR1020007006467A priority patent/KR20010033104A/ko
Priority to CN99802763A priority patent/CN1290167A/zh
Priority to CA002315375A priority patent/CA2315375A1/en
Priority to PCT/SE1999/001828 priority patent/WO2000021533A1/en
Priority to HU0101415A priority patent/HUP0101415A3/hu
Priority to AU14241/00A priority patent/AU1424100A/en
Priority to EP99970322A priority patent/EP1043997A1/en
Priority to JP2000575509A priority patent/JP2002527394A/ja
Priority to EEP200000354A priority patent/EE200000354A/xx
Priority to US09/423,200 priority patent/US6492382B1/en
Priority to SK819-2000A priority patent/SK8192000A3/sk
Priority to PL99341384A priority patent/PL341384A1/xx
Priority to SA99200678A priority patent/SA99200678A/ar
Priority to ZA200002749A priority patent/ZA200002749B/en
Priority to NO20002986A priority patent/NO20002986L/no
Priority to IS5529A priority patent/IS5529A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
SE9803517A 1998-10-15 1998-10-15 Pharmaceutical preparation SE9803517D0 (sv)

Priority Applications (20)

Application Number Priority Date Filing Date Title
SE9803517A SE9803517D0 (sv) 1998-10-15 1998-10-15 Pharmaceutical preparation
PL99341384A PL341384A1 (en) 1998-10-15 1999-10-11 Dried or frozen pharmacological preparation containing antiarrythmic compound of iii group
HU0101415A HUP0101415A3 (en) 1998-10-15 1999-10-11 3,7-diazabicyclo [3.3.1]-nonane-carboxylic acid salts, pharmaceutical preparation containing thereof, methods for their preparation and their use
EP99970322A EP1043997A1 (en) 1998-10-15 1999-10-11 A dried or frozen pharmaceutical preparation containing a class iii antiarrhythmic compound
IL13642899A IL136428A0 (en) 1998-10-15 1999-10-11 A dried or frozen pharmaceutical preparation containing a class iii antiarrhythmic compound
KR1020007006467A KR20010033104A (ko) 1998-10-15 1999-10-11 제3류 항부정맥 화합물을 함유한 건조 또는 냉동된 의약제제
CN99802763A CN1290167A (zh) 1998-10-15 1999-10-11 一种干燥的或冷冻的含有一种ⅲ级抗心律失常化合物的药用制剂
CA002315375A CA2315375A1 (en) 1998-10-15 1999-10-11 A dried or frozen pharmaceutical preparation containing a class iii antiarrhythmic compound
PCT/SE1999/001828 WO2000021533A1 (en) 1998-10-15 1999-10-11 A dried or frozen pharmaceutical preparation containing a class iii antiarrhythmic compound
BR9906869-9A BR9906869A (pt) 1998-10-15 1999-10-11 Preparações farmacêuticas seca e aquosa congelada, processos para a manufatura de uma preparação farmacêutica seca e aquosa congelada e para a profilaxia e/ou tratamento de arritmia cardìaca, sal, e, uso de um composto antiarrìtmico de classe iii
AU14241/00A AU1424100A (en) 1998-10-15 1999-10-11 A dried or frozen pharmaceutical preparation containing a class III antiarrhythmic compound
TR2000/01760T TR200001760T1 (tr) 1998-10-15 1999-10-11 Sınıf III antiarritmik bileşim içeren ispençiyari müstahzar
JP2000575509A JP2002527394A (ja) 1998-10-15 1999-10-11 クラスｉｉｉ抗不整脈化合物を含有する乾燥または凍結製剤
EEP200000354A EE200000354A (et) 1998-10-15 1999-10-11 Kuivatatud või külmutatud ravimpreparaat, mis sisaldab III klassi arütmiavastast ühendit
US09/423,200 US6492382B1 (en) 1998-10-15 1999-10-11 Dried or frozen pharmaceutical preparation containing a class III antiarrhythmic compound
SK819-2000A SK8192000A3 (en) 1998-10-15 1999-10-11 A dried or frozen pharmaceutical preparation containing a class iii antiarrhythmic compound
SA99200678A SA99200678A (ar) 1998-10-15 1999-10-16 مستحضرات مجففة محتوية على مركب مضاد اللانظمية من الفئة iii وعمليات تحضير تلك المستحضرات
ZA200002749A ZA200002749B (en) 1998-10-15 2000-06-01 A dried or frozen pharmaceutical preparation containing a class III antiarrhythmic compound.
NO20002986A NO20002986L (no) 1998-10-15 2000-06-09 Tørket eller frosset farmasøytisk preparat inneholdende en klasse III antiarytmisk forbindelse
IS5529A IS5529A (is) 1998-10-15 2000-06-13 Þurrkuð eða frosin lyfjablanda sem inniheldur efni við hjartsláttartruflunum úr flokki III

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9803517A SE9803517D0 (sv) 1998-10-15 1998-10-15 Pharmaceutical preparation

Publications (1)

Publication Number Publication Date
SE9803517D0 true SE9803517D0 (sv) 1998-10-15

Family

ID=20412957

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9803517A SE9803517D0 (sv) 1998-10-15 1998-10-15 Pharmaceutical preparation

Country Status (20)

Country Link
US (1) US6492382B1 (sv)
EP (1) EP1043997A1 (sv)
JP (1) JP2002527394A (sv)
KR (1) KR20010033104A (sv)
CN (1) CN1290167A (sv)
AU (1) AU1424100A (sv)
BR (1) BR9906869A (sv)
CA (1) CA2315375A1 (sv)
EE (1) EE200000354A (sv)
HU (1) HUP0101415A3 (sv)
IL (1) IL136428A0 (sv)
IS (1) IS5529A (sv)
NO (1) NO20002986L (sv)
PL (1) PL341384A1 (sv)
SA (1) SA99200678A (sv)
SE (1) SE9803517D0 (sv)
SK (1) SK8192000A3 (sv)
TR (1) TR200001760T1 (sv)
WO (1) WO2000021533A1 (sv)
ZA (1) ZA200002749B (sv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9803517D0 (sv) 1998-10-15 1998-10-15 Astra Ab Pharmaceutical preparation
SE9902270D0 (sv) * 1999-06-16 1999-06-16 Astra Ab Pharmaceutically active compounds
SE9903759D0 (sv) * 1999-10-18 1999-10-18 Astra Ab Pharmaceutically active compounds
CN1842320B (zh) * 2003-06-30 2013-06-19 阿尔扎公司 含有不挥发性平衡离子的用于经涂覆的微突出物的制剂
CN102026621A (zh) * 2008-05-15 2011-04-20 巴克斯特国际公司 稳定的药物制剂
EP2149370A1 (en) * 2008-07-31 2010-02-03 Neuroscienze Pharmaness S.C. A R.L. Diazabicyclic compounds and microemulsions thereof
US20220062288A1 (en) * 2020-09-02 2022-03-03 Jubilant Pharma Holdings Inc. Pharmaceutical compositions of vibegron for reducing body fat
US20220062213A1 (en) * 2020-09-02 2022-03-03 Jubilant Pharma Holdings Inc. Methods and compositions of solabegron for reducing body fat

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR950010150B1 (ko) 1986-01-14 1995-09-11 쥬우가이세이야꾸 가부시끼가이샤 니코란딜 함유 주사제의 안정화 방법
SE9704709D0 (sv) * 1997-12-17 1997-12-17 Astra Ab Pharmaceutically active compounds
SE9803517D0 (sv) 1998-10-15 1998-10-15 Astra Ab Pharmaceutical preparation

Also Published As

Publication number Publication date
WO2000021533A1 (en) 2000-04-20
CA2315375A1 (en) 2000-04-20
JP2002527394A (ja) 2002-08-27
CN1290167A (zh) 2001-04-04
SK8192000A3 (en) 2001-02-12
IL136428A0 (en) 2001-06-14
NO20002986D0 (no) 2000-06-09
PL341384A1 (en) 2001-04-09
NO20002986L (no) 2000-06-09
ZA200002749B (en) 2001-01-11
IS5529A (is) 2000-06-13
TR200001760T1 (tr) 2000-11-21
AU1424100A (en) 2000-05-01
EE200000354A (et) 2001-12-17
HUP0101415A3 (en) 2001-12-28
HUP0101415A2 (hu) 2001-11-28
US6492382B1 (en) 2002-12-10
BR9906869A (pt) 2000-10-17
KR20010033104A (ko) 2001-04-25
SA99200678A (ar) 2005-12-03
EP1043997A1 (en) 2000-10-18

Similar Documents

Publication Publication Date Title
IE900161L (en) Pyrazolopyridines
IL92730A0 (en) 2-aminopyrimidinone derivatives,their preparation and pharmaceutical compositions containing them
CA2382919A1 (en) Bicyclic imidazo-3-yl-amine derivatives
IL72354A (en) Imidazole derivatives and imidazolium salt derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
PT85411A (en) 7-]]3-(aminomethyl)-3-alkyl"-1-pyrrolidinyl"-quinoline-carboxylic acids
SE9803517D0 (sv) Pharmaceutical preparation
BR0208829A (pt) Sal farmaceuticamente aceitável, composto, processos para a preparação de um sal, de um composto e de uma forma cristalina dos compostos, formulação farmacêutica, uso de um composto, e, método de profilaxia ou tratamento de uma arritmia
ZA856943B (en) 7-(2-dialkylamino)ethyl)-4-hydroxy-1,3-benzimidazol-2-ones
ES547620A0 (es) Procedimiento para preparar pirazol (3,4-b) piridinamidas.
CA2300289A1 (en) A pharmaceutical composition active in reducing production of mcp-1 protein
NO900342L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 3-fenyl-5,6-dihydrobenz(c)akridin-7-karboxylsyrer og beslektede forbindelser.
IE801163L (en) Paromomycin derivatives
NO167286C (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzotiazepin-derivater.
NO20013601L (no) Nye morfolinobenzamidsalter
SE8601799D0 (sv) (-)-1beta-ethyl-1alfa-hydroxymethyl-1,2,3,4,6,7,12,12balfa-octahydroindolo/2,3-a/quinolizine, process for its preparation and pharmaceutical compositions containing same
EG19154A (en) Antiviral highly water soluble, stable, cujstaline salts of 2,3 dideoxyinosine monohydrate,2,3 dideoxy 2,3 didehydrothumidine monohydrate and 2,3 - dideoxy-2- fluoroinosine hemilydrate
AU3145484A (en) 1-(4'-alkylthiophenyl)-2-amino-1, 3-propanediol N-substituted derivatives
MY101266A (en) Pharmaceutical formulations
SE8204693L (sv) Lekemedel med speciellt antiarrytmisk och understodjande verkan vid hjerthypoxi och forfarande for framstellning derav
WO1987005022A3 (en) PHARMACOLOGICALLY ACTIVE OCTAHYDRO-PYRIDO(1,2-a) PYRAZINES
RU93058275A (ru) Производные тиофен-2-карбоновой кислоты, способ их получения, фармацевтическая композиция и способ ее получения
EP0306863A3 (en) New cephem compounds and processes for preparation thereof